Tobias Pöhlmann
Dr. Tobias Pöhlmann is a trained biologist and received his PhD in cancer biology from the Friedrich Schiller University Jena in 2005. He built a strong scientific network during his time as a scientist at the Ontario Veterinary College in Guelph, Ontario, Canada and at the Marine Biological Laboratory in Woods Hole, Massachusetts, USA. In the European Network of Excellence on Embryo Implantation Control he was responsible for RNAi experiments, which provided the perfect environment to start the work on RNAi-based therapeutic strategies. In 2012, Dr. Pöhlmann and Dr. Günther founded BianoScience to develop a peptide-siRNA prodrug for the treatment of breast cancer, and in 2017 BianoGMP, an oligonucleotide CDMO focused on small-scale GMP and N-of-1 projects.